Capricor Therapeutics (CAPR) Tops Q3 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. SPCX
2. LEVI
3. SBUX
4. NVDA
5. GOOGL
6. APLD
7. ORCL
8. USO
9. STZ
10. AAPL

Go back to Capricor Therapeutics (CAPR) Tops Q3 EPS by 8c

Capricor Therapeutics Reports Third Quarter 2015 Business & Financial Highlights

November 12, 2015 4:05 PM EST

LOS ANGELES, Nov. 12, 2015 /PRNewswire/ -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company focused on the discovery, development and commercialization of first-in-class therapeutics, today provided a business and financial update for the third quarter ended September 30, 2015.

Third Quarter and Recent Operational Highlights

Capricor presented positive six-month DYNAMIC (Dilated cardiomYopathy iNtervention with Allogeneic MyocardIally-regenerative Cells) clinical trial results of its cardiosphere derived cell (CDC) therapy, CAP-1002, for the... More